Antiretroviral drug costs and prescription patterns in British Columbia, Canada: 1996–2011

Por Nosyk, B, Montaner, JSG, Yip, B, Lima, VD, Hogg, RS
Publicado em 2014

Modelling the cost-effectiveness of population-level HAART expansion in British Columbia

Por Nosyk, B, Min, JE, Lima, VD, Hogg, RS, Montaner, JSG
Publicado no Lancet HIV (2015)

HIV-1 disease progression during Highly Active Antiretroviral Therapy: An application using population-level data in British Columbia: 1996–2011

Por Nosyk, B, Min, JE, Lima, VD, Yip, B, Hogg, RS, Montaner, JSG
Publicado em 2013

Rates of new infections in British Columbia continue to decline at a faster rate than in other Canadian regions

Por Hogg, RS, Nosyk, B, Harrigan, PR, Lima, VD, Chan, K, Heath, K, Wood, E, Kerr, T, Montaner, JSG
Publicado no HIV Med (2013)

Phylogenetic clustering of hepatitis C virus among people who inject drugs in Vancouver, Canada

Por Jacka, B, Applegate, T, Krajden, M, Olmstead, A, Harrigan, PR, Marshall, BDL, DeBeck, K, Milloy, M-J, Lamoury, F, Pybus, OG, Lima, VD, Magiorkinis, G, Montoya, V, Montaner, J, Joy, J, Woods, C, Dobrer, S, Dore, GJ, Poon, AF, Grebely, J
Publicado em 2014

The effect of injecting drug use history on disease progression and death among HIV-positive individuals initiating combination antiretroviral therapy: collaborative cohort analysi...

Por Murray, M, Hogg, RS, Lima, VD, May, MT, Moore, DM, Abgrall, S, Bruyand, M, Monforte, A D'Arminio, Tural, C, Gill, MJ, Harris, RJ, Reiss, P, Justice, AC, Kirk, O, Saag, M, Smith, CJ, Weber, R, Rockstroh, J, Khaykin, P, Sterne, JAC
Publicado no HIV Med (2011)